PSDV - pSivida Limited Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PSDV - pSivida Limited

PSDV 1.220

+14.0%

Mar 29 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: John McCarthy	9/29/2009 12:16:43 PM
	Read Replies (1) of 421

The PK Trials - 3 months to 18 months ... ================= 3 Month Review ================= Total Patients ----------------- High - 17 patients Low - 20 patients Improvements ============= 15 Letters or Better ------------------- High - 18% Low - 20% 10 Letters or Better ------------------- High - 29% Low - 20% (these #'s only found as antedotal in the 6 month study as follows) alimerasciences.com =================== IOP =================== greater than 30 mmHg IOP Problems ------------------- High - 12% Low - 0% alimerasciences.com ================= 6 Month Review ================= Total Patients ----------------- High - 17 patients Low - 20 patients Improvements ============= 15 Letters or Better ------------------- High - 18% Low - 10% 10 Letters or Better ------------------- High - 41% Low - 25% =================== IOP =================== greater than 30 mmHg IOP Problems ------------------- High - 12% Low - 0% alimerasciences.com ================= 12 Month Review ================= Total Patients ----------------- High - 17 patients Low - 20 patients Improvements ============= 15 Letters or Better ------------------- High - 27.3% Low - 23.1% 10 Letters or Better ------------------- High - Not Reported Low - Not Reported =================== IOP =================== greater than 30 mmHg IOP Problems ------------------- High - 23.5% Low - 0% phx.corporate-ir.net ================= 18 Month Review ================= Total Patients ----------------- High - 17 patients Low - 20 patients Modified Patients ----------------- Patients meeting the visual acuity inclusion criteria of the nearly 1000 patient Phase III FAME trial = 24 patients Doses ----------------------- High - (11 of 17 patients) Low - (13 of 20 patients) ------------------------------ Total - 24 of 37 patients ============================== improved as follows ............ Improvements ============= 15 Letters or Better ------------------- High - 36% (4 patients) Low - 0% (no Patients) 10 Letters or Better ------------------- High - 55% (6 patients) Low - 23% (3 patients) My Addition ------------- Not Reported ------------------- High - (1 patients) Low - (10 patients) =================== IOP =================== greater than 30 mmHg IOP Problems ------------------- High - 29% Low - 0% finance.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next